Eupafolin
Eupafolin is a naturally occurring compound that belongs to the flavone class of polyphenolic compounds. It is found in various plants, including the Phyla nodiflora, a species of flowering plant in the verbena family.
Chemical Structure and Properties
Eupafolin, also known as 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-methoxy-2-phenyl-4H-chromen-4-one, has a distinctive chemical structure that contributes to its biological activities. Its molecular formula is C21H16O7, and it has a molecular weight of 388.35 g/mol. The compound is characterized by its two hydroxyl groups and a methoxy group, which play a crucial role in its interactions with biological systems.
Pharmacological Activities
Research on eupafolin has revealed a wide range of pharmacological activities that make it a promising candidate for various therapeutic applications. Some of the key pharmacological properties of eupafolin include:
Anti-inflammatory Effects
Eupafolin exhibits potent anti-inflammatory properties by inhibiting the production of pro-inflammatory mediators and cytokines. Studies have shown that eupafolin can suppress the activation of inflammatory pathways, making it a potential treatment for inflammatory conditions such as arthritis and inflammatory bowel disease.
Antioxidant Activity
As a polyphenolic compound, eupafolin possesses strong antioxidant activity, which helps protect cells from oxidative stress and damage. By scavenging free radicals and reducing oxidative damage, eupafolin may play a role in preventing various chronic diseases associated with oxidative stress.
Anticancer Potential
One of the most exciting aspects of eupafolin is its potential as an anticancer agent. Research has demonstrated that eupafolin can inhibit the growth of cancer cells, induce apoptosis (programmed cell death), and suppress tumor progression. These findings suggest that eupafolin could be a valuable addition to cancer treatment regimens.
Neuroprotective Effects
Eupafolin has shown neuroprotective effects in preclinical studies, indicating its potential for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. By modulating neuronal function and protecting against neurotoxicity, eupafolin may offer new therapeutic strategies for these debilitating conditions.
Health Benefits
The pharmacological properties of eupafolin translate into a variety of potential health benefits for individuals. Some of the notable health benefits associated with eupafolin include:
Cardiovascular Health
Eupafolin's antioxidant and anti-inflammatory properties can benefit cardiovascular health by reducing the risk of atherosclerosis, hypertension, and other cardiovascular diseases. By protecting blood vessels and improving circulation, eupafolin may help maintain heart health.
Skin Health
The antioxidant activity of eupafolin makes it a promising ingredient in skincare products. By neutralizing free radicals and reducing oxidative stress, eupafolin can help protect the skin from premature aging, UV damage, and other environmental stressors.
Digestive Health
Eupafolin's anti-inflammatory effects may benefit digestive health by reducing inflammation in the gastrointestinal tract. This could be particularly beneficial for individuals with conditions such as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).
Articles/Studies
Air Pollution
Anti-Inflammatory
Anti-Viral
Cancer
- Eupafolin, a flavonoid isolated from Artemisia princeps, induced apoptosis in human cervical adenocarcinoma HeLa cells
- Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase.
- Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma.
- Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling.
- Corrigendum: Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase Protein Kinase.
- Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells.